Skip to main content
. 2021 Jan 20;38(2):1328–1341. doi: 10.1007/s12325-020-01601-w

Fig. 1.

Fig. 1

CENTAURUS study design [20]. QW once weekly, Q2W every 2 weeks, Q4W every 4 weeks, Q8W every 8 weeks, IV intravenously, PD progressive disease, LPFD last patient first dose, CR complete response.

This figure was adapted from Fig. 1a from Landgren et al. (10.1038/s41375-020-0718-z) [20], which is licensed under the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/)